Linked e-resources
Details
Table of Contents
Cover
Half Title
Title
Copyright
Contents
List of Contributors
Part I Current Trends in Pathophysiology and Post-COVID Effects
Chapter 1 Pathophysiology of SARS-CoV-2
1.1 Introduction
1.2 Structure of the Virus
1.3 Entry of SARS-CoV-2
1.4 Entry Factors of SARS-CoV2
1.5 Hallmark of COVID-19
1.5.1 Pathophysiology of SARS-CoV-2
1.6 Affecting Respiratory Tract
1.7 SARS-CoV-2 Infection Affects RAAS
1.8 Endothelial Dysfunction and Platelet Activation
1.9 Endocrine Dysfunction
1.9.1 Neuropathology
1.10 List of Abbreviations
Acknowledgement
3.2 Interactions Between SARS-CoV-2 Infection and Malaria
3.3 Similarity of Malaria and COVID-19 Symptoms and Problems Associated with It
3.4 Potential Effects of Previous Malaria Exposure on Clinical Profiles and Outcomes in Patients with SARS-CoV-2 Infection
3.5 Important Clinical Correlations of Co-Infection in High Malaria Burden Areas
3.6 Conclusion
References
Chapter 4 Interaction of COVID-19 and Tuberculosis
4.1 Introduction
4.2 Epidemiological and Clinical Presentation of COVID-19 with TB Infection
4.3 Biological Mechanism of COVID-19 and TB
4.4 Diagnostic Approaches for COVID-19 and Tuberculosis
4.4.1 Diagnostic Approaches for COVID-19
4.4.2 Smear Microscopy using Ziehl Neelsen (ZN) Staining Method
4.5 Impact of COVID-19 on TB
4.6 Conclusion
References
Chapter 5 Coinfection of SARS-CoV-2 with Viruses Causing Respiratory and Systemic Infections
5.1 Introduction
5.2 Respiratory Viral Co-Infection in COVID-19
5.2.1 Co-Infection of SARS-CoV-2 with Influenza Virus
5.2.2 Co-Infection of SARS-CoV-2 with Human Coronavirus (CoVs)
5.2.3 Co-Infection of SARS-CoV-2 with Adenovirus
5.3 Systemic Viral Co-Infection in COVID-19
5.3.1 SARS-CoV-2 and HIV Co-Infections
5.3.2 SARS-CoV-2 and CMV Co-Infections
5.3.3 SARS-CoV-2 and EBV Co-Infections
5.3.4 SARS-CoV-2 and HBV Co-Infections
5.4 Viral Co-infections: Symptoms and Diagnosis
5.5 Conclusion
References
Part III COVID-19 and Neurological Complications
Chapter 6 Neurological Association of COVID-19 and Neurodegenerative Disorders
6.1 Introduction
6.2 COVID-19 and Neurodegenerative Diseases
6.3 COVID-19 and AD
6.4 COVID-19 and PD
6.5 COVID-19 and MS
Half Title
Title
Copyright
Contents
List of Contributors
Part I Current Trends in Pathophysiology and Post-COVID Effects
Chapter 1 Pathophysiology of SARS-CoV-2
1.1 Introduction
1.2 Structure of the Virus
1.3 Entry of SARS-CoV-2
1.4 Entry Factors of SARS-CoV2
1.5 Hallmark of COVID-19
1.5.1 Pathophysiology of SARS-CoV-2
1.6 Affecting Respiratory Tract
1.7 SARS-CoV-2 Infection Affects RAAS
1.8 Endothelial Dysfunction and Platelet Activation
1.9 Endocrine Dysfunction
1.9.1 Neuropathology
1.10 List of Abbreviations
Acknowledgement
3.2 Interactions Between SARS-CoV-2 Infection and Malaria
3.3 Similarity of Malaria and COVID-19 Symptoms and Problems Associated with It
3.4 Potential Effects of Previous Malaria Exposure on Clinical Profiles and Outcomes in Patients with SARS-CoV-2 Infection
3.5 Important Clinical Correlations of Co-Infection in High Malaria Burden Areas
3.6 Conclusion
References
Chapter 4 Interaction of COVID-19 and Tuberculosis
4.1 Introduction
4.2 Epidemiological and Clinical Presentation of COVID-19 with TB Infection
4.3 Biological Mechanism of COVID-19 and TB
4.4 Diagnostic Approaches for COVID-19 and Tuberculosis
4.4.1 Diagnostic Approaches for COVID-19
4.4.2 Smear Microscopy using Ziehl Neelsen (ZN) Staining Method
4.5 Impact of COVID-19 on TB
4.6 Conclusion
References
Chapter 5 Coinfection of SARS-CoV-2 with Viruses Causing Respiratory and Systemic Infections
5.1 Introduction
5.2 Respiratory Viral Co-Infection in COVID-19
5.2.1 Co-Infection of SARS-CoV-2 with Influenza Virus
5.2.2 Co-Infection of SARS-CoV-2 with Human Coronavirus (CoVs)
5.2.3 Co-Infection of SARS-CoV-2 with Adenovirus
5.3 Systemic Viral Co-Infection in COVID-19
5.3.1 SARS-CoV-2 and HIV Co-Infections
5.3.2 SARS-CoV-2 and CMV Co-Infections
5.3.3 SARS-CoV-2 and EBV Co-Infections
5.3.4 SARS-CoV-2 and HBV Co-Infections
5.4 Viral Co-infections: Symptoms and Diagnosis
5.5 Conclusion
References
Part III COVID-19 and Neurological Complications
Chapter 6 Neurological Association of COVID-19 and Neurodegenerative Disorders
6.1 Introduction
6.2 COVID-19 and Neurodegenerative Diseases
6.3 COVID-19 and AD
6.4 COVID-19 and PD
6.5 COVID-19 and MS